AxoGen Financial Statements (AXGN)
|
|
|
|
Report date
|
|
|
25.02.2022 |
14.03.2023 |
05.03.2024 |
26.02.2025 |
24.02.2026 |
|
28.04.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
127.4 |
138.6 |
159.0 |
187.3 |
225.2 |
|
238.1 |
|
Operating Income, bln rub |
|
|
-25.4 |
-29.7 |
-21.5 |
-3.29 |
-7.85 |
|
-9.02 |
|
EBITDA, bln rub |
? |
|
-20.9 |
-23.5 |
-13.3 |
6.08 |
0.192 |
|
5.69 |
|
Net profit, bln rub |
? |
|
-27.0 |
-28.9 |
-21.7 |
-9.96 |
-15.7 |
|
-31.5 |
|
|
OCF, bln rub |
? |
|
-13.4 |
-16.1 |
-5.72 |
4.54 |
0.812 |
|
15.6 |
|
CAPEX, bln rub |
? |
|
28.4 |
21.3 |
14.9 |
4.52 |
3.75 |
|
6.62 |
|
FCF, bln rub |
? |
|
-41.8 |
-37.3 |
-20.6 |
0.011 |
-2.93 |
|
8.93 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
|
|
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
129.8 |
138.5 |
143.3 |
145.3 |
175.2 |
|
187.6 |
|
Cost of production, bln rub |
|
|
22.9 |
29.8 |
37.1 |
45.4 |
57.9 |
|
59.5 |
|
R&D, bln rub |
|
|
24.2 |
25.6 |
27.3 |
27.8 |
32.9 |
|
34.3 |
|
Interest expenses, bln rub |
|
|
1.36 |
0.624 |
2.84 |
8.21 |
7.70 |
|
14.6 |
|
|
Assets, bln rub |
|
|
208.0 |
195.4 |
196.8 |
203.7 |
221.7 |
|
289.5 |
|
Net Assets, bln rub |
? |
|
112.6 |
101.0 |
95.7 |
103.9 |
128.8 |
|
244.8 |
|
Debt, bln rub |
|
|
67.5 |
67.4 |
69.3 |
68.7 |
19.2 |
|
20.6 |
|
Cash, bln rub |
|
|
84.1 |
48.8 |
31.0 |
33.5 |
35.5 |
|
82.7 |
|
Net debt, bln rub |
|
|
-16.6 |
18.6 |
38.3 |
35.2 |
-16.3 |
|
-62.0 |
|
|
Ordinary share price, rub |
|
|
9.37 |
|
|
16.5 |
32.7 |
|
38.8 |
|
Number of ordinary shares, mln |
|
|
41.2 |
42.1 |
42.9 |
44.3 |
46.1 |
|
51.6 |
|
|
Market cap, bln rub |
|
|
386 |
0 |
0 |
729 |
1 507 |
|
2 000 |
|
EV, bln rub |
? |
|
370 |
19 |
38 |
765 |
1 491 |
|
1 938 |
|
Book value, bln rub |
|
|
110 |
97 |
91 |
98 |
122 |
|
238 |
|
|
EPS, rub |
? |
|
-0.65 |
-0.69 |
-0.51 |
-0.23 |
-0.34 |
|
-0.61 |
|
FCF/share, rub |
|
|
-1.01 |
-0.89 |
-0.48 |
0.00 |
-0.06 |
|
0.17 |
|
BV/share, rub |
|
|
2.66 |
2.31 |
2.13 |
2.22 |
2.65 |
|
4.60 |
|
|
EBITDA margin, % |
? |
|
-16.4% |
-16.9% |
-8.38% |
3.24% |
0.09% |
|
2.39% |
|
Net margin, % |
? |
|
-21.2% |
-20.9% |
-13.7% |
-5.32% |
-6.97% |
|
-13.2% |
|
FCF yield, % |
? |
|
-10.8% |
|
|
0.00% |
-0.19% |
|
0.45% |
|
ROE, % |
? |
|
-24.0% |
-28.7% |
-22.7% |
-9.59% |
-12.2% |
|
-12.8% |
|
ROA, % |
? |
|
-13.0% |
-14.8% |
-11.0% |
-4.89% |
-7.08% |
|
-10.9% |
|
|
P/E |
? |
|
-14.3 |
0.00 |
0.00 |
-73.2 |
-96.0 |
|
-63.6 |
|
P/FCF |
|
|
-9.24 |
0.00 |
0.00 |
66 307 |
-513.9 |
|
223.9 |
|
P/S |
? |
|
3.03 |
0.00 |
0.00 |
3.89 |
6.69 |
|
8.40 |
|
P/BV |
? |
|
3.52 |
0.00 |
0.00 |
7.42 |
12.3 |
|
8.42 |
|
EV/EBITDA |
? |
|
-17.7 |
-0.79 |
-2.87 |
125.8 |
7 765 |
|
340.3 |
|
Debt/EBITDA |
|
|
0.80 |
-0.79 |
-2.87 |
5.79 |
-84.9 |
|
-10.9 |
|
|
R&D/CAPEX, % |
|
|
85.1% |
120.6% |
183.3% |
613.8% |
878.1% |
|
518.1% |
|
|
CAPEX/Revenue, % |
|
|
22.3% |
15.3% |
9.38% |
2.41% |
1.66% |
|
2.78% |
|
| AxoGen shareholders |
